Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Need to clarify & very clear

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Mar 05, 2024 10:33pm

150 Views

Post# 35917189

RE:RE:RE:RE:RE:RE:RE:RE:RE:Need to clarify & very clear

It is quite possible that I am mistaken but for sure am completely frustrated as are many.
Just for confirmation of the information that I previously reported .....They had better come through with something or there is going to be a lot of explaining to do.

This is the statement from the circular

The Stock Option Plan provides that if the expiration date of an Option occurs during a “blackout period” or within
five (5) business days after a blackout period, such expiration date shall be deemed to be extended to the date which is the tenth